Using Fludarabine to Reduce Exposure to Alkylating Agents in Children with Sickle Cell Disease Receiving Busulfan, Cyclophosphamide and Anti-Thymocyte Globulin Transplant Conditioning: Results of a Dose De-escalation Trial.

Document Type

Journal Article

Publication Date

1-2015

Journal

Biology of Blood and Marrow Transplantation

Peer Reviewed

1

Link to Full Text

Share

COinS